Product Information
ALISKIREN 300 MG TABLET is a generic product labeled by Prasco Laboratories, priced at $5.6762 per EA under NDC 66993014230. Its NADAC has been published 371 times since May 22, 2019.
Strength
300 mg/1
Manufacturer
Prasco LaboratoriesNDC
66993014230
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ALISKIREN HEMIFUMARATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021985On Market Since
3/4/2019
Pharmacological Classes
Price Statistics
The NADAC for ALISKIREN 300 MG TABLET has been published 371 times since May 22, 2019, and over the history we have for it it has declined 24.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6762 per EA |
|---|---|
| All-time high | $7.7118 (May 12, 2021) |
| All-time low | $4.4638 (Jun 19, 2024) |
| 52-week high | $5.6764 |
| 52-week low | $5.0380 |
| Median price | $6.5066 |
| Average price | $6.3720 |
| Largest weekly change | +26.9% (Jun 17, 2020) |
| Weeks tracked | 371 |
| Tracking since | May 22, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALISKIREN 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALISKIREN 300 MG TABLET, manufactured by Prasco Laboratories, is $5.6762 per EA (NDC 66993014230), effective Jun 24, 2026.
How has the price of ALISKIREN 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALISKIREN 300 MG TABLET has declined 24.0%. It has been tracked across 371 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for ALISKIREN 300 MG TABLET?
Since May 22, 2019, the NADAC for ALISKIREN 300 MG TABLET has ranged from a low of $4.4638 (Jun 19, 2024) to a high of $7.7118 (May 12, 2021), with a median of $6.5066 per EA.
Are there cheaper alternatives to ALISKIREN 300 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ALISKIREN 300 MG TABLET, but none are currently priced below it.
Who manufactures ALISKIREN 300 MG TABLET?
ALISKIREN 300 MG TABLET (NDC 66993014230) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.